Stocks

Ameriprise (AMP) Q3 Earnings Beat, Revenues & Costs Rise Y/Y

Ameriprise Financial’s AMP third-quarter 2021 adjusted operating earnings per share of $5.91 surpassed the Zacks Consensus Estimate of $5.46. The bottom line reflects a rise of 38.4% from the year-ago quarter.

Results were aided by growth in revenues, partly offset by higher expenses. Improvements in assets under management (AUM) and assets under administration (AUA) balance were tailwinds.

After considering significant items, net income (GAAP basis) was $1.03 billion or $8.65 per share against a net loss of $140 million or $1.14 per share in the prior-year quarter.

Revenues Improve, Expenses Rise

On an operating basis, total adjusted net revenues (excluding unlocking) were $3.50 billion, up 17.4% year over year. The top line missed the Zacks Consensus Estimate of $3.54 billion. On a GAAP basis, net revenues were $2.90 billion, down 3.3% year over year.

Adjusted operating expenses (excluding unlocking) totaled $2.64 billion, up 14.2% from the prior-year quarter.

AUM & AUA Improve

Driven by solid client flows in the Wealth and Asset Management segments and market appreciation, total AUM and AUA were $1.21 trillion, up 20.8% year over year.

Share Repurchase Update

In the reported quarter, Ameriprise repurchased shares worth $533 million.

Conclusion

In July, Ameriprise closed its fixed annuity reinsurance transaction for RiverSource Life Insurance Company with Global Atlantic’s subsidiary, Commonwealth Annuity and Life Insurance Company.

The company’s solid AUM balance, diversified investment portfolio and business-restructuring efforts are expected to keep aiding profitability. However, rising expenses make us apprehensive.

Ameriprise Financial, Inc. Price, Consensus and EPS Surprise

 

Ameriprise Financial, Inc. Price, Consensus and EPS Surprise

Ameriprise Financial, Inc. price-consensus-eps-surprise-chart | Ameriprise Financial, Inc. Quote

Ameriprise currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Performance of Other Asset Managers

BlackRock, Inc.’s BLK third-quarter 2021 adjusted earnings of $10.95 per share outpaced the Zacks Consensus Estimate of $9.63. The figure reflects a rise of 18.8% from the year-ago quarter’s number.

Blackstone’s BX third-quarter 2021 distributable earnings of $1.28 per share comfortably surpassed the Zacks Consensus Estimate of 93 cents. The figure reflects a significant rise from 63 cents recorded in the prior-year quarter.

SEI Investments Co.’s SEIC third-quarter 2021 earnings of 97 cents per share were in line with the Zacks Consensus Estimate. The bottom line reflected 29% growth from the prior-year quarter.


Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $2.4 trillion by 2028 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Recommendations from previous editions of this report have produced gains of +205%, +258% and +477%. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Click to get this free report

Blackstone Inc. (BX): Free Stock Analysis Report

BlackRock, Inc. (BLK): Free Stock Analysis Report

Ameriprise Financial, Inc. (AMP): Free Stock Analysis Report

SEI Investments Company (SEIC): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Other Topics

Investing

Latest Stocks Videos

JPMorgan Says Buy the Dip as Investors Face Volatility

Dec 02, 2021

Zacks

Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

Learn More